ESCaping Rejection: A Step Forward for Embryonic-Stem-Cell-Based Regenerative Medicine

The use of human embryonic stem cells (hESCs) for regenerative medicine currently faces several hurdles, including immune rejection of transplanted cells. Now in Cell Stem Cell, Rong et al. (2014) describe a strategy to protect hESCs from immune rejection while avoiding systemic immunosuppression, p...

Full description

Saved in:
Bibliographic Details
Published in:Cell stem cell 2014-01, Vol.14 (1), p.3-4
Main Authors: Willinger, Tim, Flavell, Richard A.
Format: Article
Language:English
Subjects:
Animals
Cell Differentiation
Cell- and Tissue-Based Therapy
Embryonic Stem Cells - cytology
Embryonic Stem Cells - immunology
Graft Rejection - prevention & control
Humans
Immunosuppression
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The use of human embryonic stem cells (hESCs) for regenerative medicine currently faces several hurdles, including immune rejection of transplanted cells. Now in Cell Stem Cell, Rong et al. (2014) describe a strategy to protect hESCs from immune rejection while avoiding systemic immunosuppression, potentially facilitating clinical implementation of hESC-based therapies.
ISSN:1934-5909
1875-9777
DOI:10.1016/j.stem.2013.12.003